10 Best Online Semaglutide Providers (Comparisons)

If you've watched a sporting event recently, you've seen an advertisement for Ro. Their consumer experience is incredibly polished, boasting a beautiful app interface and highly responsive customer service teams. Their compounding pharmacies are top-tier.

However, you are paying a massive premium to fund that massive corporate overhead. Ro's compounded semaglutide program typically starts around $249 per month (and compounded tirzepatide often exceeds $349). While they may waive the first month's "membership fee" to get you in the door, the recurring costs add up staggeringly fast. It is a highly reputable service, but you are effectively paying $100+ more per month than Telehealth FX for the exact same active ingredient.

Hims & Hers has successfully translated their success in the hair loss and ED markets into the weight loss sector. The clinical oversight is robust, and the packaging is highly aesthetic. They frequently advertise a highly competitive monthly rate for compounded semaglutide (often around $199/mo).

The major caveat? To secure that advertised rate, you are usually required to prepay for 6 to 12 months of medication at checkout. This forces the patient to front $1,200 to $2,400 immediately. If you attempt to pay on a month-to-month basis, the monthly price spikes significantly. This pricing structure is designed to lock consumers in and eliminate corporate churn, transferring all financial risk to the patient.

Henry Meds helped pioneer the compounded telehealth space. Their baseline rate of roughly $199 per month for semaglutide is competitive, and their clinical network is vast. However, their pricing model is deeply flawed for long-term patients.

If your physician determines that your body has acclimated to the starting dose and you require a higher clinical dosage to continue losing weight, Henry Meds applies a "step-up" fee—often adding $100 to your monthly bill. Furthermore, if you wish to upgrade to tirzepatide, their pricing jumps closer to $349/month. This model effectively punishes patients as they progress through their treatment journey.

WeightWatchers acquired telehealth startup Sequence to enter the GLP-1 space. Their specific value proposition is their "insurance concierge" team. If you have a phenomenal health insurance policy that covers weight loss medications, the Sequence team will fight the prior authorization battles for you.

However, if your insurance inevitably denies coverage (as most do), Sequence is arguably the worst option on this list. They primarily prescribe name-brand medications (Ozempic/Wegovy), leaving you to pay the $1,000+ retail cost at the pharmacy counter. Furthermore, they charge a $99 monthly membership fee simply to remain on the platform, meaning you pay $99/mo just for the privilege of accessing a doctor, on top of your massive pharmacy bill.

Found originally built its business model on prescribing cheap, off-label oral medications (like Metformin or Contrave) and charging a heavy premium for access to their diet coaches and behavioral app. When GLP-1s revolutionized the market, Found struggled to adapt.

Today, if you source GLP-1s through Found, you are forced to subsidize their massive coaching infrastructure. This pushes the monthly cost well above $300. Because GLP-1 medications naturally eliminate "food noise" on a biological level, forcing patients to pay a premium for an app coach is financially inefficient for the vast majority of users.

Similar to WeightWatchers, Noom realized their psychological diet app was losing ground to actual medical interventions, so they launched Noom Med. To access their clinical team, you must first subscribe to the baseline Noom app, and then pay an additional premium for the Med tier.

Once inside, you face the same issues as Sequence: if your insurance denies the brand-name medication, you are left paying the full retail price at CVS, while still paying Noom a monthly fee for their app. It is a highly fragmented and expensive patient experience.

PlushCare is a massive general telehealth platform (think sinus infections and pink eye). They recently bolted on a weight loss program to capitalize on the GLP-1 trend. Because weight loss is not their primary focus, their logistics are not vertically integrated.

You pay a monthly membership fee, plus a co-pay for the doctor visit, and then you are sent to a local pharmacy with a script for a brand-name medication. Unless you have stellar insurance, this results in a $1,000+ monthly retail bill.

Sesame operates an open marketplace. You scroll through a list of independent doctors, pay a one-time consultation fee, and they write your script. Recently, Sesame partnered with compounding pharmacies to offer a compounded semaglutide program starting around $189.

However, because you are dealing with independent gig-economy doctors rather than a unified clinical team, the patient experience varies wildly. One doctor may be highly responsive; another may take days to adjust a dosage. The lack of centralized clinical continuity makes it a frustrating long-term option.

Local aesthetic MedSpas have pivoted heavily into offering "Weight Loss Shots." This is almost universally a terrible financial decision for the consumer. These local clinics purchase compounded semaglutide from the exact same 503A national pharmacies used by telehealth platforms.

They then mark the price up by 300% to cover the cost of their expensive retail rent, receptionist salaries, and marble countertops. We routinely see local clinics charging $500 to $800 per month for the exact same medication you can get shipped to your door for $146 from Telehealth FX.